You are here

PROTHERA BIOLOGICS, INC.

Company Information
Address
349 EDDY ST
PROVIDENCE, RI 02903-4204
United States


https://www.protherabiologics.com/

Information

UEI: ZAE3CABBMZE9

# of Employees: 5


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. Inter-alpha Inhibitors in Hypoxic-Ischemic Brain Injury

    Amount: $2,776,920.00

    Perinatal brain injury resulting in mental retardation and cerebral palsy is the most severe disability in children and affects 40-148 in preterm and 1–2/1000 in full term infants. This places a hug ...

    SBIRPhase II2023Department of Health and Human Services National Institutes of Health
  2. Inter-alpha Inhibitors in Experimental Necrotizing Enterocolitis

    Amount: $378,272.00

    Necrotizing enterocolitis (NEC) is a devastating acute inflammatory condition of the gastrointestinal tract resulting in intestinal necrosis, systemic sepsis and multi-system organ failure found mostl ...

    SBIRPhase I2023Department of Health and Human Services National Institutes of Health
  3. Rapid Test to Assist Therapy in Neonatal Sepsis and Necrotizing Enterocolitis

    Amount: $1,862,493.00

    The primary goal of this proposed research is to develop a rapid point-of-care test that assesses the risk of neonatal sepsis (NS) and/or necrotizing enterocolitis (NEC) in infants based on Inter-alph ...

    SBIRPhase II2019Department of Health and Human Services National Institutes of Health
  4. Rapid Test to Assist Therapy in Neonatal Sepsis and Necrotizing Enterocolitis

    Amount: $166,522.00

    The primary goal of this proposed research is to develop a rapid point of care test that assesses the risk of neonatal sepsisNSand or necrotizing enterocolitisNECin infants based on Inter alpha inhibi ...

    SBIRPhase I2018Department of Health and Human Services National Institutes of Health
  5. Inter-alpha Inhibitors in Hypoxic-Ischemic Brain Injury

    Amount: $1,925,615.00

    Neonatal hypoxia ischemiaHIremains a major cause of acute perinatal brain injuryleading ultimately to neurologic dysfunction manifesting as cerebral palsymental retardationand epilepsyUnfortunatelycur ...

    SBIRPhase II2017Department of Health and Human Services National Institutes of Health
  6. Therapeutic Role of Inter-alpha Inhibitors in Wound Healing

    Amount: $224,688.00

    DESCRIPTION provided by applicant Wound healing is an intricately regulated process broadly characterized by phases of inflammation proliferation and remodeling Imbalances in any one of these ph ...

    SBIRPhase I2015Department of Health and Human Services National Institutes of Health
  7. Inter-alpha-inhibitors in Hypoxic-Ischemic Brain Injury

    Amount: $203,226.00

    DESCRIPTION (provided by applicant): Neonatal hypoxia-ischemia (HI) remains a major cause of acute perinatal brain injury, leading ultimately to neurologic dysfunction manifesting as cerebral palsy, ...

    SBIRPhase I2014Department of Health and Human Services National Institutes of Health
  8. Rapid detection of neonatal sepsis

    Amount: $498,061.00

    DESCRIPTION (provided by applicant): The primary goal of this proposed research is to develop a rapid point-of-care (POC) test that can be used to identify neonatal sepsis in high-risk infants in a si ...

    SBIRPhase I2012Department of Health and Human Services National Institutes of Health
  9. Role of Inter-alpha Inhibitors in Anthrax Intoxication

    Amount: $2,679,880.00

    DESCRIPTION (provided by applicant): Anthrax is recognized as a class A bio-threat microbial pathogen that is readily weaponized and exceedingly difficult to treat. This bacterium is highly virulent i ...

    STTRPhase II2010Department of Health and Human Services National Institutes of Health
  10. Bioprocessing of Plasma Therapeutic Proteins using Sequential Affinity Monolithic

    Amount: $170,547.00

    DESCRIPTION (provided by applicant): Plasma fractionation is one of the largest industry segments in global therapeutic protein manufacture. The United States plays an important role in this industry ...

    SBIRPhase I2007Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government